Preparation and assessment of an optimized multichannel acellular nerve allograft for peripheral nerve regeneration by Tianhao Yu, Qiang Ao, Tianrang Ao, Muhammad Arslan Ahmad, Aijun Wang, Yingxi Xu, Zhongti Zhang, Qing Zhou

Get full text

<i>AML1-ETO</i>-Related Fusion Circular RNAs Contribute to the Proliferation of Leukemia Cells by Ying Wang, Yu Liu, Yingxi Xu, Haiyan Xing, Zheng Tian, Kejing Tang, Qing Rao, Min Wang, Jianxiang Wang

Get full text

Correction: Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells by Nianci Chen, Yingxi Xu, Junli Mou, Qing Rao, Haiyan Xing, Zheng Tian, Kejing Tang, Min Wang, Jianxiang Wang

Get full text

933 Heme-mediated reprogramming guides CD8+ T cell exhaustion in response to mitochondrial dysfunction by Alfred Zippelius, Ping-Chih Ho, Rahul Roychoudhuri, Zhengtao Xiao, Yu-Ming Chuang, Yingxi Xu, Jhan-Jie Peng, Maryam Akrami

Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells by Ying Wang, Yingxi Xu, Saisai Li, Jia Liu, Yanyan Xing, Haiyan Xing, Zheng Tian, Kejing Tang, Qing Rao, Min Wang, Jianxiang Wang

Get full text

A novel fusion protein TBLR1-RARα acts as an oncogene to induce murine promyelocytic leukemia: identification and treatment strategies by Shouyun Li, Xue Yang, Shuang Liu, Yirui Chen, Haiyan Xing, Kejing Tang, Zheng Tian, Yingxi Xu, Qing Rao, Min Wang, Jianxiang Wang

Get full text

SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. by Si Chen, Yingxi Xu, Yanan Chen, Xuefei Li, Wenjun Mou, Lina Wang, Yanhua Liu, Ralph A Reisfeld, Rong Xiang, Dan Lv, Na Li

Get full text

2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies by Yingxi Xu, Qian Liu, Mengjun Zhong, Zhenzhen Wang, Zhaoqi Chen, Yu Zhang, Haiyan Xing, Zheng Tian, Kejing Tang, Xiaolong Liao, Qing Rao, Min Wang, Jianxiang Wang

Get full text

A novel and efficient CD22 CAR-T therapy induced a robust antitumor effect in relapsed/refractory leukemia patients when combined with CD19 CAR-T treatment as a sequential therapy by Yu Zhang, Saisai Li, Ying Wang, Yang Lu, Yingxi Xu, Qing Rao, Huijun Wang, Haiyan Xing, Zheng Tian, Kejing Tang, Lulu Lv, Min Wang, Jianxiang Wang

Get full text

Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy by Manling Chen, Xiaoyu Liu, Nan Peng, Ting Zhang, Junli Mou, Huizhen He, Ying Wang, Yingxi Xu, Haiyan Xing, Kejing Tang, Zheng Tian, Qing Rao, Runxia Gu, Shaowei Qiu, Min Wang, Jianxiang Wang

Get full text

Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity by Zhenzhen Wang, Yang Lu, Yu Liu, Junli Mou, Xiaoyu Liu, Manling Chen, Ying Wang, Yingxi Xu, Qing Rao, Haiyan Xing, Kejing Tang, Zheng Tian, Bing Wang, Wei Qi, Min Wang, Shaowei Qiu, Dongsheng Xiong, Jianxiang Wang

Get full text

Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia by Runxia Gu, Fang Liu, Dehui Zou, Yingxi Xu, Yang Lu, Bingcheng Liu, Wei Liu, Xiaojuan Chen, Kaiqi Liu, Ye Guo, Xiaoyuan Gong, Rui Lv, Xia Chen, Chunlin Zhou, Mengjun Zhong, Huijun Wang, Hui Wei, Yingchang Mi, Lugui Qiu, Lulu Lv, Min Wang, Ying Wang, Xiaofan Zhu, Jianxiang Wang

Get full text